NUC7738 Induces Apoptosis Through Modulating Stability of P53 in Esophageal Cancer Cells
Journal of Biochemical and Molecular Toxicology · 2025-02 · 39 (2)
DOI: 10.1002/jbt.70175 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 18.02.2025. Verfasst von Lin-Feng Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Apoptosis, Esophageal Neoplasms, Tumor Suppressor Protein p53, Deoxyadenosines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: This study was supported by the National Natural Science Foundation of China (82172787)..
Abstract (Originalsprache)
Esophageal cancer is an aggressive malignancy with a poor prognosis. NUC7738, a cordycepin derivative, has shown promise in overcoming the limited in vivo efficacy of its parent compound. This study compares the anticancer effects of NUC7738 and cordycepin in esophageal cancer and explores the molecular mechanisms of NUC7738 action. In vitro, NUC7738 and cordycepin were tested on normal (Het1A) and esophageal cancer cell lines (ECA109, KYSE510) using Cell Counting Kit‐8 (CCK‐8) and colony formation assays. Apoptosis was confirmed by inhibitors and flow cytometry. Western blot was performed to detect apoptosis‐related protein. KEGG analysis identified potential downstream signaling pathways, while qPCR, western blot, and immunofluorescence staining were applied to assess p53 expression and stability. In vivo, ECA109 cells were xenografted into nude mice, and tumor tissues were analyzed for p53 expression using Immunohistochemical staining. Finally, CCK‐8, colony formation, and subcutaneous tumor xenograft assays in nude mice were employed to assess the synergistic effects of NUC7738 and cisplatin. The results revealed that NUC7738, although less effective than cordycepin in vitro, demonstrated superior anticancer activity in vivo. NUC7738 induced apoptosis by stabilizing p53 via ubiquitination, inhibiting tumor growth. Additionally, NUC7738 combined with cisplatin showed enhanced anticancer effects both in vitro and in vivo. These findings highlight greater potential of NUC7738 for clinical application, particularly in improving p53 stability and augmenting chemotherapeutic efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endoscopy Center and Endoscopy Research Institute, Zhongshan Hospital, Fudan University, Shanghai, China.
- Department of Endoscopy, Shanghai Collaborative Innovation Center, Shanghai, China.
- Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Förderung
- This study was supported by the National Natural Science Foundation of China (82172787).
Zitieren
APA
Wu, L. F., Ren, C. H., Xu, J. C., Zhang, Y. F., Liu, Y. B., Zhou, P. H., & Zhang, Y. Q. (2025). NUC7738 Induces Apoptosis Through Modulating Stability of P53 in Esophageal Cancer Cells. Journal of Biochemical and Molecular Toxicology, 39(2). https://doi.org/10.1002/jbt.70175
Vancouver
Wu LF, Ren CH, Xu JC, Zhang YF, Liu YB, Zhou PH, et al. NUC7738 Induces Apoptosis Through Modulating Stability of P53 in Esophageal Cancer Cells. Journal of Biochemical and Molecular Toxicology. 2025;39(2). doi:10.1002/jbt.70175
BibTeX
@article{Wu2025,
author = {Wu, Lin-Feng and Ren, Chang-Hao and Xu, Jia-Cheng and Zhang, Yi-Fei and Liu, Yan-Bo and Zhou, Ping-Hong and Zhang, Yi-Qun},
title = {NUC7738 Induces Apoptosis Through Modulating Stability of P53 in Esophageal Cancer Cells},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2025},
volume = {39},
number = {2},
doi = {10.1002/jbt.70175}
}
EUVIMED